Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Life Sciences
Combating Obesity Through Gut Microbiome Targeted Bacteriophage Therapy, Jeffrey Gongze Zhao, Laura C. Bridgewater
Combating Obesity Through Gut Microbiome Targeted Bacteriophage Therapy, Jeffrey Gongze Zhao, Laura C. Bridgewater
Library/Life Sciences Undergraduate Poster Competition 2017
Obesity has become a serious health issue in the world (Ogden 2012), and its correlation to the human gut microbiota has been studied extensively since 2007 (Cani 2007). In 2013, researchers identified Enterobacter cloacae B29 from an obese patient’s gut and demonstrated its causal relationship to the host’s obese symptoms( Fei & Zhao 2013). However, there have not been many methods developed to alleviate obesity symptoms through eliminating pathogenic endotoxin-producing bacteria (such as E. cloacae B29), from the host’s gut flora. In this research, I propose a new strategy for treating obesity by using gut microbiome targeted bacteriophage therapy. …
Uric Acid Levels In Relation To Progression Of Multiple Sclerosis, Alexander A. Gosch, Mary F. Davis, Joshua C. Denny
Uric Acid Levels In Relation To Progression Of Multiple Sclerosis, Alexander A. Gosch, Mary F. Davis, Joshua C. Denny
Library/Life Sciences Undergraduate Poster Competition 2017
Multiple sclerosis (MS) is a neurodegenerative disease caused by demyelination in the central nervous system. In previous studies, serum uric acid (UA) levels have been implied as a useful biomarker in understanding MS disease progression and development. The majority of previous studies have found MS patients have a lower UA level than healthy controls, however some studies have found higher UA levels with MS patients. Previous studies have compared UA levels between subtypes of MS, but have not produced conclusive data. To better understand the correlation between UA levels and MS patients, we compared UA levels between our set of …